Atara Biotherapeutics, Inc(NASDAQ:ATRA) 
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr viru...
Website: http://www.atarabio.com
Founded: 2012
Full Time Employees: 429
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.78
H 5.95
L 5.42
C 5.59
V 100,292
10EMA 5.59
20EMA 5.59
60EMA 5.59
120EMA 5.59
250EMA 5.59